Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Reasons driving treatment modification in Parkinson's disease: results from the cross-sectional phase of the REASON study.

Tinazzi M, Abbruzzese G, Antonini A, Ceravolo R, Fabbrini G, Lessi P, Barone P; REASON Study Group.

Parkinsonism Relat Disord. 2013 Dec;19(12):1130-5. doi: 10.1016/j.parkreldis.2013.08.006. Epub 2013 Aug 28.

PMID:
23993249
2.

Adherence to anti-Parkinson drug therapy in the "REASON" sample of Italian patients with Parkinson's disease: the linguistic validation of the Italian version of the "Morisky Medical Adherence Scale-8 items".

Fabbrini G, Abbruzzese G, Barone P, Antonini A, Tinazzi M, Castegnaro G, Rizzoli S, Morisky DE, Lessi P, Ceravolo R; REASON study group.

Neurol Sci. 2013 Nov;34(11):2015-22. doi: 10.1007/s10072-013-1438-1. Epub 2013 Jun 1.

PMID:
23728715
3.

The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life.

Antonini A, Barone P, Marconi R, Morgante L, Zappulla S, Pontieri FE, Ramat S, Ceravolo MG, Meco G, Cicarelli G, Pederzoli M, Manfredi M, Ceravolo R, Mucchiut M, Volpe G, Abbruzzese G, Bottacchi E, Bartolomei L, Ciacci G, Cannas A, Randisi MG, Petrone A, Baratti M, Toni V, Cossu G, Del Dotto P, Bentivoglio AR, Abrignani M, Scala R, Pennisi F, Quatrale R, Gaglio RM, Nicoletti A, Perini M, Avarello T, Pisani A, Scaglioni A, Martinelli PE, Iemolo F, Ferigo L, Simone P, Soliveri P, Troianiello B, Consoli D, Mauro A, Lopiano L, Nastasi G, Colosimo C.

J Neurol. 2012 Dec;259(12):2621-31. doi: 10.1007/s00415-012-6557-8. Epub 2012 Jun 19.

PMID:
22711157
4.

Stereotypic behaviors in degenerative dementias.

Prioni S, Fetoni V, Barocco F, Redaelli V, Falcone C, Soliveri P, Tagliavini F, Scaglioni A, Caffarra P, Concari L, Gardini S, Girotti F.

J Neurol. 2012 Nov;259(11):2452-9. doi: 10.1007/s00415-012-6528-0. Epub 2012 May 31.

PMID:
22648476
5.

Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders.

Marconi R, Antonini A, Barone P, Colosimo C, Avarello TP, Bottacchi E, Cannas A, Ceravolo MG, Ceravolo R, Cicarelli G, Gaglio RM, Giglia L, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Del Dotto P, De Gaspari D, Grasso L, Morgante F, Santangelo G, Fabbrini G, Morgante L; PRIAMO study group.

Neurol Sci. 2012 Jun;33(3):585-93. doi: 10.1007/s10072-011-0807-x. Epub 2011 Nov 3.

PMID:
22048791
6.

Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression.

Morgante L, Colosimo C, Antonini A, Marconi R, Meco G, Pederzoli M, Pontieri FE, Cicarelli G, Abbruzzese G, Zappulla S, Ramat S, Manfredi M, Bottacchi E, Abrignani M, Berardelli A, Cozzolino A, Paradiso C, De Gaspari D, Morgante F, Barone P; PRIAMO Study Group.

J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):76-82. doi: 10.1136/jnnp-2011-300043. Epub 2011 Aug 11.

PMID:
21836035
7.

A case-control study of Parkinson's disease and tobacco use: gene-tobacco interactions.

De Palma G, Dick FD, Calzetti S, Scott NW, Prescott GJ, Osborne A, Haites N, Mozzoni P, Negrotti A, Scaglioni A, Mutti A; Geoparkinson Study Group.

Mov Disord. 2010 May 15;25(7):912-9. doi: 10.1002/mds.22980.

PMID:
20461808
8.

Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study.

Colosimo C, Morgante L, Antonini A, Barone P, Avarello TP, Bottacchi E, Cannas A, Ceravolo MG, Ceravolo R, Cicarelli G, Gaglio RM, Giglia L, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Del Dotto P, Simoni L, Marconi R; PRIAMO STUDY GROUP.

J Neurol. 2010 Jan;257(1):5-14. doi: 10.1007/s00415-009-5255-7. Epub 2009 Aug 9.

PMID:
19669613
9.

The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease.

Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, Bottacchi E, Cannas A, Ceravolo G, Ceravolo R, Cicarelli G, Gaglio RM, Giglia RM, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Dotto PD; PRIAMO study group.

Mov Disord. 2009 Aug 15;24(11):1641-9. doi: 10.1002/mds.22643.

PMID:
19514014
10.

[Computerized medical records in monitoring hypertension. Longitudinal and horizontal evaluation of 25 general practitioners in a primary care setting of Modena, Italy].

Perrone E, Padula MS, Scarpa M, Acerbi MA, Andreoli C, Baldoni P, BannĂ² G, Bregoli R, Campolieti M, Cataldo N, Daya G, D'Urso AR, Feltri G, Gualandrini A, Lambertini G, Mazzi W, Modafferi GP, Mussati P, Onesti L, Piancone C, Pieralisi F, Poppi MC, Scaglioni A, Tsoutsis N, Turrini S, Viola E, Capelli O.

Recenti Prog Med. 2009 Jan;100(1):4-8. Italian.

PMID:
19445274
11.

Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study.

Santangelo G, Morgante L, Savica R, Marconi R, Grasso L, Antonini A, De Gaspari D, Ottaviani D, Tiple D, Simoni L, Barone P; PRIAMO Study Group.

Parkinsonism Relat Disord. 2009 Sep;15(8):576-81. doi: 10.1016/j.parkreldis.2009.02.004. Epub 2009 Apr 10.

PMID:
19362509
12.

The PRIAMO study: background, methods and recruitment.

Antonini A, Colosimo C, Marconi R, Morgante L, Barone P; PRIAMO study group.

Neurol Sci. 2008 Apr;29(2):61-5. doi: 10.1007/s10072-008-0863-z. Epub 2008 May 16.

PMID:
18483702
13.

Muscarinic cholinergic mediation of the GH response to gamma-hydroxybutyric acid: neuroendocrine evidence in normal and parkinsonian subjects.

Volpi R, Chiodera P, Caffarra P, Scaglioni A, Malvezzi L, Saginario A, Coiro V.

Psychoneuroendocrinology. 2000 Feb;25(2):179-85.

PMID:
10674281
14.

Neural basis of endogenous and exogenous spatial orienting. A functional MRI study.

Rosen AC, Rao SM, Caffarra P, Scaglioni A, Bobholz JA, Woodley SJ, Hammeke TA, Cunningham JM, Prieto TE, Binder JR.

J Cogn Neurosci. 1999 Mar;11(2):135-52.

PMID:
10198130
15.

Different control mechanisms of growth hormone (GH) secretion between gamma-amino- and gamma-hydroxy-butyric acid: neuroendocrine evidence in Parkinson's disease.

Volpi R, Chiodera P, Caffarra P, Scaglioni A, Saccani A, Coiro V.

Psychoneuroendocrinology. 1997 Oct;22(7):531-8.

PMID:
9373886
16.

Orienting of visual attention in Alzheimer's disease: its implication in favor of the interhemispheric balance.

Caffarra P, Riggio L, Malvezzi L, Scaglioni A, Freedman M.

Neuropsychiatry Neuropsychol Behav Neurol. 1997 Apr;10(2):90-5.

PMID:
9150508
17.

Defective 5-HT 1-receptor-mediated neurotransmission in the control of growth hormone secretion in Parkinson's disease.

Volpi R, Caffarra P, Scaglioni A, Boni S, Saginario A, Chiodera P, Coiro V.

Neuropsychobiology. 1997;35(2):79-83.

PMID:
9097298
18.

ACTH/cortisol involvement in the serotonergic disorder affecting the parkinsonian brain.

Volpi R, Caffarra P, Boni S, Scaglioni A, Malvezzi L, Saginario A, Chiodera P, Coiro V.

Neuropsychobiology. 1997;35(2):73-8.

PMID:
9097297
19.

Low-dose ovine corticotropin-releasing hormone stimulation test in diabetes mellitus with or without neuropathy.

Coiro V, Volpi R, Capretti L, Speroni G, Caffarra P, Scaglioni A, Malvezzi L, Castelli A, Caffarri G, Rossi G, et al.

Metabolism. 1995 Apr;44(4):538-42.

PMID:
7723679
20.

Differing patterns of psychiatric impairment in Alzheimer and demented parkinsonian patients.

Soliveri P, Zappacosta MB, Austoni L, Caffarra P, Scaglioni A, Testa D, Palazzini E, Caraceni T, Girotti F.

Ital J Neurol Sci. 1994 Nov;15(8):407-11.

PMID:
7875958

Supplemental Content

Loading ...
Support Center